Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. was established in 1990 and is located in the beautiful Miyun Economic Development Zone of Beijing. The company was the experimental pharmaceutical factory of China Medical Research and Development Center when it was founded. In 2006, it was reorganized into a private enterprise and renamed "Beijing Zhongxin Pharmaceutical Factory". Against the backdrop of the rapid development of the country's economic and technological level, seizing the opportunity and pioneering innovation, the company has made great progress and development in its business scale and technical level, and has grown into a integrated research, development, production and sales of pharmaceutical products. Comprehensive pharmaceutical companies. In 2016, the company was renamed Beijing Zhongxin Pharmaceutical Co., Ltd. In 2021, the company was renamed Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. and became a member of Shenzhen Haiwang Group.

Beijing Haiwang Zhongxin Pharmaceutical holds 137 national drug approval documents, covering 16 functional fields such as antimicrobials, anti-psychiatric disorders, cardiovascular, respiratory, digestive, and urinary system. Among them, there are 90 national medical insurance varieties, 60 national basic drugs, and 31 OTC over-the-counter drugs. They are common drugs that are essential for urgent needs in the national medical system. The industry demand is strong and the market capacity is huge.

The company currently has 3 production workshops with a construction area of ​​10,000 square meters. It has multiple modern production lines such as tablets, capsules, powders, etc. The production equipment is at the advanced level of the same industry in China, and has achieved intelligent operation and automated production. The main production and inspection equipment have been introduced to foreign first-class brands to ensure the rigor and accuracy of product inspection.

The company is currently a national high-tech enterprise, Zhongguancun high-tech enterprise, Beijing specialized, specialized, and new small and medium-sized enterprises, and has obtained the Beijing New Technology and New Product Certificate.

Since its establishment, the company has adhered to the corporate purpose of "innovation and good medicine for the people", strictly abide by the national drug industry laws and regulations, standardize production and operation order, improve the quality assurance system, ensure the quality of drugs, and provide high-quality and safe medicines to the majority of patients. We will strive to become a leading enterprise in China's oral solid preparation production.